By comparing drug-induced gene expression patterns in the striatum, a team identifies the cardiac drug SB-0107 as a potential adjunct therapy for #ParkinsonsDisease that boosts L-DOPA’s benefits in macaques while mitigating dyskinesia. @aa_bordba https://t.co/1EFEiCvplL
UC San Diego is 10-1! 🔱
Not the Tritons normal efficiency from the outside, yet still a 10pt road win at LMU.
Defense forced 18 TOs, and the rebounding was fantastic. Balanced offense too.
3rd road win for @UCSDmbb. 7th win away from home. Matchup vs San Diego up next.
Sinopia Secures Grant Funding from the National Institute of General Medical Sciences to Advance Proprietary Metabolomics Platform https://t.co/BQahtJeN8b #news#biotech
Sinopia Biosciences (@aa_bordba) selects lead clinical candidate (SB-0110) & secures funding to advance into the clinic for #Parkinsons; Agent has "unique & potentially transformative pharmacology for treating both the symptoms of PD" & dyskinesias
https://t.co/44YrFkbAjz
SDBN Feed: Sinopia Awarded Grant from National Institute of Dental and Craniofacial Research for Oral Mucositis via SDBN Blog, News: SAN DIEGO–(BUSINESS WIRE)–Sinopia has been awarded a grant from the ... #sandiego#biotech https://t.co/EImVpUR8p8
Petco Park has been named @MLB’s No. 1 Ballpark in 2022 by USA Today!
1. Petco Park – San Diego Padres
2. Oracle Park – San Francisco Giants
3. PNC Park – Pittsburgh Pirates
4. Wrigley Field – Chicago Cubs
5. Dodger Stadium – Los Angeles Dodgers
https://t.co/XtfpJChDvD
Jack Welch was revered at Biogen when I was there in the late 90s and early 00s, especially "stacked ranking" and the idea that you should fire the bottom 10% of employees every year. But the long-term damage to corporate culture is now quite clear. https://t.co/IG0wFWANrT
.@UCSDmbb erased an 11-point first half deficit to win 80-67 at Cal, making them 1-0 vs. the Pac-12 Conference as a member of NCAA Division I! 🔱 #TritonPride#GoTritons https://t.co/WCbpXybZxj
He left his native Iran on a quest to research a cure for his father's illness. The technique he developed has the potential to help people everywhere. https://t.co/IciybvFxqS
Sinopia has been awarded a $3.3 million Fast-Track SBIR grant to fund the study for its small molecule candidate for Parkinson’s disease.
#parkinsonsdisease#funding#preclinicalstudy
Learn more here: https://t.co/VgeOrVimmN
Sinopia Biosciences has been awarded a $3.3 million Fast-Track SBIR grant from NINDS to fund investigational new drug (IND)-enabling studies for Sinopia’s small molecule candidate for Parkinson’s disease (PD). https://t.co/XWLKNcIlMR via @Yahoo
Sinopia Biosciences Awarded Grant from National Institute of General Medical Sciences for Metabolomics-Based High-Throughput Screening https://t.co/dDPcfaz3IO via @Yahoo